Page last updated: 2024-10-30

loratadine and Musculoskeletal Pain

loratadine has been researched along with Musculoskeletal Pain in 2 studies

Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.

Musculoskeletal Pain: Discomfort stemming from muscles, LIGAMENTS, tendons, and bones.

Research Excerpts

ExcerptRelevanceReference
"Type of cancer, treatment, age, and BMI were not significant predictors of bone pain."1.46Prevention of granulocyte-colony stimulating factor (G-CSF) induced bone pain using double histamine blockade. ( Abrams, M; Gavioli, E, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Gajarawala, SN1
Pelkowski, JN1
DeStephano, CC1
Gavioli, E1
Abrams, M1

Other Studies

2 other studies available for loratadine and Musculoskeletal Pain

ArticleYear
Can loratadine help in treating granulocyte-colony stimulating factor-induced bone pain?
    JAAPA : official journal of the American Academy of Physician Assistants, 2021, Jul-01, Volume: 34, Issue:7

    Topics: Bone Diseases; Granulocyte Colony-Stimulating Factor; Humans; Loratadine; Musculoskeletal Pain; Reco

2021
Prevention of granulocyte-colony stimulating factor (G-CSF) induced bone pain using double histamine blockade.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2017, Volume: 25, Issue:3

    Topics: Aged; Antineoplastic Agents; Bone Diseases; Cohort Studies; Famotidine; Febrile Neutropenia; Female;

2017